Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.
about
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic reviewCost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalMagnitude and Predictors of Anti-Retroviral Treatment (ART) Failure in Private Health Facilities in Addis Ababa, EthiopiaPrevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania.Religion and HIV in Tanzania: influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes.Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic reviewUnplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay"Just like fever": a qualitative study on the impact of antiretroviral provision on the normalisation of HIV in rural Tanzania and its implications for prevention.Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland.Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.Understanding HIV disclosure: a review and application of the Disclosure Processes ModelMagnitude and predictors of antiretroviral treatment failure among HIV-infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study.One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India.Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda.Patient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific RegionFollow-Up Visit Patterns in an Antiretroviral Therapy (ART) programme in Zomba, Malawi.Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems.Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya.Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysisGender-specific risk factors for virologic failure in KwaZulu-Natal: automobile ownership and financial insecurity.Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa.Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in NigeriaAssociation between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania.Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in CambodiaAssociation of first-line and second-line antiretroviral therapy adherence.Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study.Efficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: results from the TREAT Asia HIV observational databaseRandomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy.Persistent difficulties in switching to second-line ART in sub-saharan Africa--a systematic review and meta-analysis.HIV-positive status disclosure in patients in care in rural South Africa: implications for scaling up treatment and prevention interventionsDepression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.Survival of AIDS patients treated with traditional chinese medicine in rural central china: a retrospective cohort study, 2004-2012Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South AfricaHIV as a chronic disease considerations for service planning in resource-poor settings.Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa.HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.
P2860
Q26823588-640E2B89-E402-4173-9B8B-8EEE594E9268Q28476337-58C8943F-C88B-4003-9B86-45D52EED1FCBQ28547030-648B3566-286A-4252-B40A-B6AB9B6A184FQ30370160-374AED73-4CFA-4D4C-8E64-932775021781Q30486523-24829DA7-1F2A-4AEC-A68C-FEC6412D3EA8Q31010456-0E1B9556-1A88-423E-8A7E-442A2F439B40Q33390354-C9938FEB-804F-46E1-BD4B-BE50AE76D348Q33497943-E11776BB-299B-42BE-BC93-55D98BA0C5ADQ33501383-94A94B9C-5E51-461D-BE80-59C019CA4518Q33650413-C9B7010D-6C2B-45A9-9959-714C068C9F1AQ33717359-F72C08F5-AA51-4992-9A42-7B0EDC933303Q33763992-AE595C9E-26FF-4823-B817-DB4695D6D46EQ33771383-2D4B01BE-263C-4422-8244-B3F188D4E485Q33807513-078DB20F-7095-4F5E-A465-0E0F41EFEEC9Q33815906-029AFDEC-C846-464A-9F4F-EB9DB9C57E4BQ33873540-A037E9F8-0862-4CE2-BBA4-ED0D3E7DDC2BQ33916232-288B4BD6-774F-414D-91AC-157A17C3786AQ33952538-137A0A56-0E12-43FC-A2CC-EECB86A64B86Q34049680-490A254C-A696-4007-8E67-D56EA309B14AQ34092713-8DA70A9E-4415-43F3-9894-C41BEB514EA4Q34103635-0F7CE2AE-FF26-4E8E-AD4C-86C0A5A6A901Q34345205-B1337C9B-5987-466D-ACD0-25DC6EB10E0EQ34539445-6862579D-BC70-4AD2-9B4B-87A253401942Q34604679-95644831-CD5F-4410-B96E-E980C98EAD89Q34630565-535A195C-0231-48E4-BB82-34386976F0E3Q34707535-94FA23AD-E3C5-47EC-9A4F-4EA2BC1E2F99Q34730386-AEE02914-726B-42EF-942B-97EF532E37EDQ34801978-59C684ED-D074-4FC6-B71A-E27E664E00DCQ34812918-1408DBCC-69FE-4222-8E00-76DB539CBAFFQ34963950-6B8677E7-137C-44E2-8ACD-52E3E05C4D41Q34977431-D4F50AB4-BC5D-4161-8B28-C9AF954F95D2Q35006953-DCF35CE9-7AB1-4C0C-BD72-B5A0D4EAF820Q35077695-4F1D31A3-06BE-48E4-83A2-7FB0E14AFE23Q35133519-05E52991-0835-43AD-8B78-20FA7464B1FBQ35177350-E8363835-0CFC-4051-9604-0FADEAA7DB6BQ35188327-A9A0B6E8-DC57-4C9A-8699-81A4D25F3DEFQ35217629-EC7915F9-663B-403F-B469-00CAC1A86CEEQ35397167-998FF4D1-8787-4C2E-9E17-EA8BBC740634Q35810497-04FD6906-4FB9-4BE3-A764-719303181EE5Q35917583-C5178FA0-7DAA-4DF8-8C13-3CD431FC869A
P2860
Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Predictors of incomplete adher ...... etroviral therapy in Tanzania.
@en
Predictors of incomplete adher ...... etroviral therapy in Tanzania.
@nl
type
label
Predictors of incomplete adher ...... etroviral therapy in Tanzania.
@en
Predictors of incomplete adher ...... etroviral therapy in Tanzania.
@nl
prefLabel
Predictors of incomplete adher ...... etroviral therapy in Tanzania.
@en
Predictors of incomplete adher ...... etroviral therapy in Tanzania.
@nl
P2093
P2860
P921
P356
P1476
Predictors of incomplete adher ...... etroviral therapy in Tanzania.
@en
P2093
Evaline M Ndosi
Habib O Ramadhani
Humphrey J Shao
Jennifer L Kirchherr
John A Bartlett
John F Shao
Jonathan D McNeill
Keren Z Landman
Nathan M Thielman
P2860
P304
P356
10.1086/522991
P407
P50
P577
2007-10-22T00:00:00Z